Check back in a few minutes

Server Maintenance

Your server is going through a few minutes of routine maintenance. Please don't touch your browser for a few minutes.

What do I do?

  • If you were posting a comment or making a post on your blog then do not press BACK on your browser. Wait 5 minutes and press the refresh icon on your browser. Your comment or post will be sent as normal.
  • If you are browsing a blog here just wait a few moments and hit refresh. The page you were expecting will appear.

Leukemia: Why Gleevec Got Approved

When officials at the FDA take just 2 1/2 months to approve a new cancer treatment, you know it's got to be some kind of breakthrough. And indeed the drug called Gleevec, which was given the go-ahead last week in record time, has produced dramatic results in patients with a rare malignancy called chronic myeloid leukemia. It's too early to say just how good Gleevec is. But the drug's success so far makes one thing clear. When designing a safe, effective treatment for a particular cancer, it pays to learn as much as possible about its underlying molecular biology.

Chronic myeloid...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!